By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$59.85
+$3.45
+6.12%
Last Update: 1 Sept 2025, 05:25
$2.30B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$14.00 - $65.55
52 Week Range

6609.HK Stock Price Chart

Explore Shanghai HeartCare Medical Technology Corporation Limited interactive price chart. Choose custom timeframes to analyze 6609.HK price movements and trends.

6609.HK Company Profile

Discover essential business fundamentals and corporate details for Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

20 Aug 2021

Employees

344.00

CEO

Guohui Wang

Description

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.

6609.HK Financial Timeline

Browse a chronological timeline of Shanghai HeartCare Medical Technology Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 20 May 2025

Earnings released on 31 Dec 2024

EPS came in at -$0.12 , while revenue for the quarter reached $79.47M .

Earnings released on 30 Sept 2024

EPS came in at -$0.12 surpassing the estimated -$0.23 by +46.80%, while revenue for the quarter reached $82.67M , missing expectations by -58.74%.

Earnings released on 30 Aug 2024

EPS came in at -$0.07 surpassing the estimated -$0.18 by +60.16%, while revenue for the quarter reached $68.99M , missing expectations by -55.81%.

Earnings released on 20 May 2024

EPS came in at -$0.07 , while revenue for the quarter reached $69.50M .

Earnings released on 28 Mar 2024

EPS came in at -$0.56 surpassing the estimated -$1.14 by +51.08%, while revenue for the quarter reached $65.83M , missing expectations by -50.38%.

Earnings released on 31 Dec 2023

EPS came in at -$0.58 , while revenue for the quarter reached $67.93M .

Earnings released on 31 Aug 2023

EPS came in at -$0.81 surpassing the estimated -$1.30 by +37.30%, while revenue for the quarter reached $62.55M , missing expectations by -46.02%.

Earnings released on 30 Jun 2023

EPS came in at -$0.77 , while revenue for the quarter reached $59.25M .

Earnings released on 20 Mar 2023

EPS came in at -$1.91 surpassing the estimated -$2.52 by +24.32%, while revenue for the quarter reached $58.40M , missing expectations by -48.88%.

Earnings released on 31 Dec 2022

EPS came in at -$1.98 , while revenue for the quarter reached $60.54M .

Earnings released on 1 Sept 2022

EPS came in at -$1.08 surpassing the estimated -$1.99 by +45.79%, while revenue for the quarter reached $47.27M , missing expectations by -44.22%.

Earnings released on 30 Jun 2022

EPS came in at -$1.03 , while revenue for the quarter reached $44.90M .

Earnings released on 29 Mar 2022

EPS came in at -$1.70 , while revenue for the quarter reached $36.16M .

Earnings released on 31 Dec 2021

EPS came in at -$1.72 , while revenue for the quarter reached $36.71M .

Earnings released on 30 Aug 2021

EPS came in at -$1.59 , while revenue for the quarter reached $19.82M .

Earnings released on 10 Aug 2021

EPS came in at -$1.20 , while revenue for the quarter reached $16.13M .

Earnings released on 31 Dec 2020

EPS came in at -$5.10 , while revenue for the quarter reached $7.36M .

Earnings released on 30 Sept 2020

EPS came in at -$4.90 , while revenue for the quarter reached $7.06M .

6609.HK Stock Performance

Access detailed 6609.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run